CD4 and breast carcinoma: For example, early diagnosed older breast cancer patients showed increased frequencies of CD8+ T cells, their cytotoxic sub-types and CD4+ effector memory T cells after 3 months of chemotherapy, although the frequencies of CD8+ central memory T cells and the CD4+/CD8+ ratio decreased (Bailur et al., 2017).